MIC discrepancies between parenteral and oral anti-staphylococcal β-lactams among MSSA
Conclusions: The variations in MICs observed compounded with the dosing and pharmacokine tic differences of oral vs IV β-lactam suggests that establishing breakpoints for oral β-lactam antibiotics is necessary to ensure adequate therapy is selected for the treatment of complex S. aureus infections.
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Antibiotic Therapy | Cancer & Oncology | Cephalexin | Chemotherapy | Laboratory Medicine | Staphylococcus Aureus | Study